Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy

Neuromuscular Disability Clinical Trial

Official title:

Effects of Standing on Non-Ambulatory Children With Spinal Muscular Atrophy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02341053
• Other study ID #: 1411M55281
• Status: Completed
• Phase: N/A
• Start date: September 8, 2016
• Est. completion date: July 25, 2018

Study information

• Verified date: February 2021
• Source: Gillette Children's Specialty Healthcare
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Non-ambulatory children with a neuromuscular disability such as spinal muscular atrophy (SMA) are at significant risk for poor bone health as defined by low bone mineral density (BMD) and increased propensity to fracture. Poor bone health is thought to be related, at least in part, to abnormally low levels of load experienced by the skeleton. A common physical approach for increasing bone density is to stimulate the musculoskeletal system by increasing the amount and duration of weight-bearing in the lower extremities. For non-ambulatory individuals, this takes the form of using an assisted standing device to enable the child to spend time in a standing position with some degree of weight placed on the lower limbs. Some of these physical interventions demonstrate variable improvement in BMD in children with neuromuscular conditions, and some do not. A serious limitation in the previous work in this area is a failure to objectively measure the magnitude and duration of the loading experienced by the lower extremities. Thus, a lack of change in BMD may be due to the extremities experiencing only a fraction of the body weight (due to load-sharing with the assistive device) for an inadequate duration of standing time. In order to investigate the efficacy of standing treatment for increasing BMD, the investigators will develop a simple, portable and inexpensive transducer that will measure the magnitude and time course of the load experienced by the lower extremities of individuals with SMA who use a stationary assisted standing device. The specific goal of this proposed project will be to develop, validate and establish the initial feasibility of such a measurement device.

Description:

Background: Non-ambulatory children with a neuromuscular disability such as spinal muscular atrophy (SMA) are at significant risk for poor bone health as defined by low bone mineral density (BMD) and increased propensity to fracture. Poor bone health is thought to be related, at least in part, to abnormally low levels of load experienced by the skeleton. A common physical approach for increasing bone density is to stimulate the musculoskeletal system by increasing the amount and duration of weight-bearing in the lower extremities. For non-ambulatory individuals, this takes the form of using an assisted standing device to enable the child to spend time in a standing position with some degree of weight placed on the lower limbs. Some of these physical interventions demonstrate variable improvement in BMD in children with neuromuscular conditions, and some do not. A serious limitation in the previous work in this area is a failure to objectively measure the magnitude and duration of the loading experienced by the lower extremities. Thus, a lack of change in BMD may be due to the extremities experiencing only a fraction of the body weight (due to load-sharing with the assistive device) for an inadequate duration of standing time. Methods: In order to investigate the efficacy of standing treatment for increasing BMD, we will develop a simple, portable and inexpensive transducer that will measure the magnitude and time course of the load experienced by the lower extremities of individuals with SMA who use a stationary assisted standing device. This transducer will consist of an array of sensors embedded within a mat that will be placed under an individual's feet while they are in assisted standing. A prototype will be validated by comparing the output of this load-sensing mat against known loads that will be applied to the surface of the mat statically. The specific characteristics of the loading in the lower extremities of subjects can then be correlated with changes in their BMD to obtain a true outcome assessment. As a demonstration of this approach, we will recruit 3 children with SMA from Gillette Children's Specialty Healthcare who are currently participating in a standing program. Once enrolled and informed consent is obtained, the participants will use the mat provided to them to collect load and duration data during a baseline period where they will continue their standing program, and during a subsequent intervention period where they will increase the duration of their standing. The specific goal of this proposed project will be to develop, validate and establish the initial feasibility of such a measurement device. Implications: Successful completion of this proposed project will provide the necessary groundwork to move forward with a multicenter clinical trial on a large number of subjects with a variety of neuromuscular conditions. The measurement device will allow us to correlate change in BMD with the specific load history for each participant, thereby allowing us to determine whether physical interventions can lead to increased BMD in individuals with neuromuscular disabilities. Analysis of the data will help define a dose-dependent relationship between load, duration and changes in BMD, thereby guiding providers and therapists in prescribing standing interventions.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 4
• Est. completion date: July 25, 2018
• Est. primary completion date: July 25, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 3 Years to 14 Years

Eligibility

Inclusion Criteria:

1. Age 3-14 years old

2. Diagnosed with Spinal Muscular Atrophy (SMA)

3. Participating in a standing program using a stationary assisted standing device.

4. Gross Motor Function Classification System (GMFCS) Level IV or V

5. Parent must be able to provide consent.

Exclusion Criteria:

1. Currently on bisphosphonates

Related Conditions & MeSH terms

• Atrophy
• Muscular Atrophy
• Muscular Atrophy, Spinal
• Muscular Dystrophies
• Neuromuscular Disability
• Spinal Muscular Dystrophy

Intervention

Other:
• Assisted Standing Treatment Program
Assisted Standing Treatment Program - Assisted standing treatment program will be gradually increase duration of standing by up to 75% after baseline.

Locations

Country	Name	City	State
United States	Gillette Children's Specialty Healthcare	Saint Paul	Minnesota

Sponsors (2)

Lead Sponsor	Collaborator
Gillette Children's Specialty Healthcare	University of Minnesota

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Collection of load magnitude and duration data (Use load-sensing platforms to collect load magnitude and duration during standing treatment program)	Use load-sensing platforms to collect load magnitude and duration during standing treatment program.	12 months
Secondary	Bone Mineral Density	Determine whether an increase in the duration of standing leads to improvements in BMD, fracture incidence, pulmonary function and quality of life, and whether there is evidence that relationships exist between these outcome measures and load magnitude and duration.	12 months